Retatrutide is an investigational triple agonist that has not been approved by any regulator. That means almost everything published about it outside the trial literature is first-person: people filming their own weeks, their own numbers and their own side effects. The videos collected here are exactly that, and they are useful only as a window onto what individuals report — not as a substitute for the phase 2 data summarised on the compound profile.
These videos represent individual experiences and anecdotes. They should not be interpreted as clinical evidence or medical advice.
Week-by-week diaries, usually built around a scale reading and a photo comparison
Nausea, appetite suppression and fatigue described in the first days after a change in amount
Confusion about reconstitution arithmetic, which is why each page links to the calculator
Sourcing and legality discussions, which frequently shade into promotional content
Why this is not evidence
A person filming a video has chosen to film it. People whose experience was unremarkable, or who stopped early, are systematically less likely to appear. Nothing shown here is controlled, blinded, verified or representative, and a cluster of similar-sounding videos does not establish that a compound is effective or safe.
Most of the videos currently curated for Retatrutide are promotional or commercial rather than independent personal accounts. They are shown here labelled as such, not presented as experiences.
42 curated Retatrutide videos
Promotional / commercialYouTube
Retatrutide Results So Strong, People Quit! PHASE 3 RESULTS
DOWNSIZED · 12 Dec 2025 · 83K views
Commercial or promotional content referencing Retatrutide, Semaglutide, Tirzepatide. Creator's own description opens: “Retatrutide’s startling Phase 3 results are finally here — and the numbers are unlike anything we’ve ever seen in obesity medicine.”
Hosted on YouTube by Dizzll TV. Any claims made are the creator's own and have not been independently verified.
Promotional / commercialYouTube
GLP-1 / Zepbound / Tirzepatide Journey | 6 Month update, the good and the bad!
Riding the -tide · 4 May 2026 · 52K views
Commercial or promotional content referencing Retatrutide, Semaglutide, Tirzepatide. Creator's own description opens: “In this video I celebrate the 6 month milestone on a GLP-1 journey and share my ups and downs.”
Hosted on YouTube by Dizzll TV. Any claims made are the creator's own and have not been independently verified.
Promotional / commercialYouTube
GLP-1 Tirzepatide Journey | I made the move to Compounded and Titrated up to 7.5 mg...
Riding the -tide · 20 Aug 2026 · 18K views
Commercial or promotional content referencing Retatrutide, Semaglutide, Tirzepatide. Creator's own description opens: “In this video I explain why I decided to change from Zepbound to compounded Tirzepatide, the decision to titrate up to 7.5mg and break down why I landed on Join Belle.”